JPMorgan Chase & Co’s Atossa Therapeutics ATOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.28K | Sell |
2,741
-116,188
| -98% | -$96.4K | ﹤0.01% | 5635 |
|
|
2025
Q1 | $80K | Sell |
118,929
-242,367
| -67% | -$163K | ﹤0.01% | 4836 |
|
|
2024
Q4 | $341K | Buy |
361,296
+211,654
| +141% | +$200K | ﹤0.01% | 4321 |
|
|
2024
Q3 | $227K | Buy |
149,642
+95,643
| +177% | +$145K | ﹤0.01% | 4414 |
|
|
2024
Q2 | $64.3K | Buy |
53,999
+53,905
| +57,346% | +$64.1K | ﹤0.01% | 4809 |
|
|
2024
Q1 | $169 | Hold |
94
| – | – | ﹤0.01% | 5814 |
|
|
2023
Q4 | $83 | Hold |
94
| – | – | ﹤0.01% | 6101 |
|
|
2023
Q3 | $69 | Hold |
94
| – | – | ﹤0.01% | 5993 |
|
|
2023
Q2 | $118 | Hold |
94
| – | – | ﹤0.01% | 5771 |
|
|
2023
Q1 | $0 | Hold |
94
| – | – | ﹤0.01% | 5789 |
|
|
2022
Q4 | $0 | Hold |
94
| – | – | ﹤0.01% | 5562 |
|
|
2022
Q3 | $0 | Hold |
94
| – | – | ﹤0.01% | 5515 |
|
|
2022
Q2 | $0 | Sell |
94
-54,866
| -100% | – | ﹤0.01% | 5570 |
|
|
2022
Q1 | $69K | Buy |
54,960
+11,683
| +27% | +$14.7K | ﹤0.01% | 4887 |
|
|
2021
Q4 | $69K | Sell |
43,277
-34,797
| -45% | -$55.5K | ﹤0.01% | 4956 |
|
|
2021
Q3 | $254K | Sell |
78,074
-78,250
| -50% | -$255K | ﹤0.01% | 4296 |
|
|
2021
Q2 | $988K | Buy |
+156,324
| New | +$988K | ﹤0.01% | 3647 |
|
|
2019
Q4 | – | Sell |
-11,354
| Closed | -$22K | – | 4690 |
|
|
2019
Q3 | $22K | Buy |
+11,354
| New | +$22K | ﹤0.01% | 4461 |
|